安图生物：2025年前三季度净利润约8.60亿元

Company Performance - Antu Biology reported a revenue of approximately 3.127 billion yuan for the first three quarters of 2025, representing a year-on-year decrease of 7.48% [1] - The net profit attributable to shareholders was about 860 million yuan, down 10.11% year-on-year [1] - Basic earnings per share were 1.5 yuan, reflecting a decrease of 9.09% compared to the previous year [1] Market Overview - As of the report, Antu Biology's market capitalization stood at 22.1 billion yuan [2] - The A-share market has surpassed 4000 points, indicating a significant market resurgence after a decade of stagnation, with a new "slow bull" market pattern emerging [2]